Table 5.
Level of evidence | Strength of recommendation | |
---|---|---|
Strong | Weak | |
High | Topiramate | Valproic acid |
Divalproex sodium | Flunarizine | |
Propranolol | ||
Metoprolol | ||
Moderate | Amitriptyline | Atenolol |
Nadolol | ||
Candesartan | ||
Low | Nebivolol | |
Cinnarizine | ||
Lisinopril | ||
Levetiracetam | ||
Zonisamide |
Adapted from Im and Cho [38] according to the Creative Commons License.